3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
10
Non-Muscle Invasive Bladder Neoplasms
6
Peritoneal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Transitional Cell
3
Appendiceal Neoplasms
3
Anus Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Peritoneal Diseases
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Necrosis
1
Male Urogenital Diseases
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Female Urogenital Diseases
1
Anal Canal Carcinoma
1
Interventions
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
abemaciclib
1
Nivolumab
1
Injections
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cyclophosphamide
1
Cisplatin
1
Cetuximab
1
Biological Products
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Squamous Cell
×
Mitomycin
×
90 days
×
Clear all
No trials found.